It is a trading private limited company based in Uttam Nagar Near Sanatan Dharam Mandir, Delhi, India, established in 2014.
2014 | Uttam Nagar Near Sanatan Dharam Mandir, Delhi, India | ActiveMedila Pharmaceuticals Private Limited, a active private limited company, was established on 24 January 2014 in Uttam Nagar Near Sanatan Dharam Mandir, Delhi, India. Engaging in other wholesale within the trading sector, it holds CIN: U24100DL2014PTC263976. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Ravi Prakash (Director), Anaagat (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at O-29, Block–O F/F Vijay Vihar, Uttam Nagar Near Sanatan Dharam Mandir, Delhi, 110059.
U24100DL2014PTC263976
263976
24 January 2014
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Medila Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravi Prakash | Director | 24 Jan 2014 | Current |
| Anaagat | Director | 24 Jan 2014 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medila Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 51.27% decrease. The company also saw a substantial fall in profitability, with a 12.17% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2016, Medila Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medila Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medila Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medila Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medila Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
The activity Medila Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was completed.
Ravi Prakash was appointed as a Director was appointed as a Director on 24 Jan 2014 & has been associated with this company since 11 years 11 months . was recorded as a recent event.
The activity Anaagat was appointed as a Director was appointed as a Director on 24 Jan 2014 & has been associated with this company since 11 years 11 months . was completed.
The activity Medila Pharmaceuticals Private Limited was registered on 24 Jan 2014 with Roc Delhi & aged 11 years 11 months as per MCA records. was completed.
The CIN of Medila Pharmaceuticals Private Limited is U24100DL2014PTC263976.
Medila Pharmaceuticals Private Limited is headquartered at O-29, Block–O F/F Vijay Vihar, Uttam Nagar Near Sanatan Dharam Mandir, Delhi, 110059.
Medila Pharmaceuticals Private Limited was incorporated on 24 January 2014.
The current directors of Medila Pharmaceuticals Private Limited are
The primary industry of Medila Pharmaceuticals Private Limited is Trading.
Medila Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medila Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Medila Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX